Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials for Cancer in United States

7944 results

Sort By:

Bladder and Bone Effects of Pelvic Radiation Therapy in Childhood Cancer Survivors

Study ID: NCT05818462
Start Date: 2023-07-11
End Date: 2026-12
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

60

Intervention / Treatment

Uroflow testing

Bladder Scan

Dysfunctional Voiding Scoring System Survey

DEXA Scan of pelvis and sacral spine

Urine tests for specific biomarkers

Sponsor

University of Colorado, Denver

Source: clinicaltrials.gov

Share:
Add to list

Entrectinib as a Single Agent in Upfront Therapy for Children <3 Years of Age With NTRK1/2/3 or ROS1-FUSED CNS Tumors

Study ID: NCT06528691
Start Date: 2025-05
End Date: 2032-11
Study Type

Interventional

Study Phase

Phase2

No. of Participants

52

Intervention / Treatment

Entrectinib

Cyclophosphamide

Etoposide

Carboplatin

G-CSF

Freak

Surgery

Sponsor

St. Jude Children's Research Hospital

Source: clinicaltrials.gov

Share:
Add to list

Collection of Blood in Studying Metabolites in Patients With Prostate Cancer

Study ID: NCT03485794
Start Date: 2017-11-14
End Date: 2026-11-14
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

10

Intervention / Treatment

Biospecimen Collection

Laboratory Biomarker Analysis

Sponsor

University of Southern California

Source: clinicaltrials.gov

Share:
Add to list

A Study of Intra-operative Imaging in Women With Ovarian Cancer

Study ID: NCT04878094
Start Date: 2021-05-03
End Date: 2025-05-03
Study Type

Interventional

Study Phase

Phase3

No. of Participants

310

Intervention / Treatment

Intravenous Indocyanine Green/ICG injection

PINPOINT endoscopic fluorescence imaging system

Endoscopy

Sponsor

Memorial Sloan Kettering Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors

Study ID: NCT06541262
Start Date: 2024-10-30
End Date: 2035-11-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

114

Intervention / Treatment

Eye -catching

Irinotecan

Temozolomide

Vincristine

Sponsor

Milton S. Hershey Medical Center

Source: clinicaltrials.gov

Share:
Add to list

Novel Subtypes of Polycystic Ovary Syndrome

Study ID: NCT06124391
Start Date: 2021-01-01
End Date: 2025-12-30
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

50000

Intervention / Treatment

Long-term follow-up

Sponsor

Shandong University

Source: clinicaltrials.gov

Share:
Add to list

Met Non Small Cell Cancer Registry (MOMENT)

Study ID: NCT05376891
Start Date: 2022-10-04
End Date: 2027-03-31
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

700

Intervention / Treatment
Sponsor

EMD Serono Research & Development Institute, Inc.

Source: clinicaltrials.gov

Share:
Add to list

Studying the Effect of Levocarnitine in Protecting the Liver From Chemotherapy for Leukemia or Lymphoma

Study ID: NCT05602194
Start Date: 2023-08-24
End Date: 2028-12-30
Study Type

Interventional

Study Phase

Phase3

No. of Participants

440

Intervention / Treatment

Biospecimen Collection

CALASPARGASE PEGOL

Levocarnitine

Pegaspargase

Quality-of-Life Assessment

Sponsor

Children's Oncology Group

Source: clinicaltrials.gov

Share:
Add to list

Infusion System for Hepatic Cancer

Study ID: NCT04684862
Start Date: 2021-02-08
End Date: 2029-07
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

100

Intervention / Treatment

Medtronic SynchroMed II programmable pump connected to an Intera tapered catheter (Combined Infusion System)

Sponsor

Ronald Dematteo, M.D.

Source: clinicaltrials.gov

Share:
Add to list

In Vivo Metabolic Profiling of CLL (Chronic Lymphocytic Leukemia)

Study ID: NCT04785989
Start Date: 2022-06-13
End Date: 2025-10
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

16

Intervention / Treatment

[U-13C]glucose

[13C5]glutamine

Sponsor

University of Wisconsin, Madison

Source: clinicaltrials.gov

Share:
Add to list